Malignant pleural effusions treated with high dose intrapleural doxycycline: clinical efficacy and tolerance.

  • Authors:
    • A Prevost
    • P Nazeyrollas
    • D Milosevic
    • A Fernandez-Valoni
  • View Affiliations

  • Published online on: March 1, 1998     https://doi.org/10.3892/or.5.2.363
  • Pages: 363-369
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Chronic malignant pleural effusion may be treated by instillating products in the pleural space to induce pleurodesis. We used intrapleural doxycycline at doses greater than 2000 mg in 16 malignant pleural effusion (14 patients). Patient survival ranged from 1 day to 19.5 months. Mean drainage duration was 7.5 days (range, 5-10 days). Pain (moderate n=7; severe n=2) was the most frequent side-effect with hypotension (moderate n=3; severe n=1). Five cases were not evaluable at one month because of death during the month following treatment (n=3) or during treatment (n=2). At one month follow-up, success was defined as no pleural effusion (n=5), partial response as minimal effusion (n=4) and we considered that treatment had failed if pleural drainage was necessary (n=2). Five patients died within one month and 5 had more than 3 months survival (4 without recurrence).

Related Articles

Journal Cover

Mar-Apr 1998
Volume 5 Issue 2

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Prevost A, Nazeyrollas P, Milosevic D and Fernandez-Valoni A: Malignant pleural effusions treated with high dose intrapleural doxycycline: clinical efficacy and tolerance.. Oncol Rep 5: 363-369, 1998
APA
Prevost, A., Nazeyrollas, P., Milosevic, D., & Fernandez-Valoni, A. (1998). Malignant pleural effusions treated with high dose intrapleural doxycycline: clinical efficacy and tolerance.. Oncology Reports, 5, 363-369. https://doi.org/10.3892/or.5.2.363
MLA
Prevost, A., Nazeyrollas, P., Milosevic, D., Fernandez-Valoni, A."Malignant pleural effusions treated with high dose intrapleural doxycycline: clinical efficacy and tolerance.". Oncology Reports 5.2 (1998): 363-369.
Chicago
Prevost, A., Nazeyrollas, P., Milosevic, D., Fernandez-Valoni, A."Malignant pleural effusions treated with high dose intrapleural doxycycline: clinical efficacy and tolerance.". Oncology Reports 5, no. 2 (1998): 363-369. https://doi.org/10.3892/or.5.2.363